Protein profiling of the supratentorial primitive neuroectodermal tumor (pnet) cell line pfsk-1

Cancer Genomics and Proteomics

Volumn 1, Issue 2, 2004, Pages 125-136

  Peyrl, Andreas ^a   Krapfenbauer, Kurt ^b   Afjehi Sadat, Leila ^a   Strobel, Thomas ^b   Slavc, Irene ^a   Lubec, Gert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Brain tumor; PFSK 1; Proteomics; StPNET

Indexed keywords

EID: 12844272586     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Pollak IF: Brain tumors in children. N Engl J Med 331: 1500-1507, 1994.
2. Hart MN and Earle KM: Primitive neuroectodermal tumors of the brain in children. Cancer 32: 890-897, 1973.
3. Rorke LB: The cerebellar MB and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol 42: 1-15, 1983.
4. Rubinstein LJ: Embryonal central neuroepithelial tumors and their differentiating potential: a cytogenetic view of a complex neuro-oncological problem. J Neurosurg 62: 795-805, 1985.
5. Reddy AT, Janss AJ, Phillips PC, Weiss HL and Packer RJ: Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy. Cancer 88: 2189-2193, 2000.
6. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, Mc Laughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES and Golub TR: Prediction of central nervous system embryonal tumour outcome expression. Nature 415: 436-442, 2002.
7. Fults D, Pedone CA, Morse HG, Rose JW and McKay RD: Establishment and characterization of a human primitive neuroectodermal tumor cell line from the cerebral hemisphere. J Neuropathol Exp Neurol 51: 272-280, 1992.
8. Jae-Kyung M, Gulesserian T, Fountoulakis M and Lubec G: Deranged hypothetical proteins Rik protein, Nit protein 2 and mitochondrial inner membrane protein, Mitofilin, in fetal Down syndrome brain. Cell Mol Biol (Noisy-le-grand) 49: 739-746, 2003.
9. Peyrl A, Krapfenbauer K, Slavc I, Yang JW, Strobel T and Lubec G: Protein profiles of medulloblastoma cell lines DAOY and D283: identification of tumor-related proteins and principles. Proteomics 3: 1781-1800, 2003.
10. Lubec G, Krapfenbauer K and Fountoulakis M: Proteomics in brain research: potentials and limitations. Progr Neurobiol 69: 193-2111, 2003.
11. Engidawork E, Gulesserian T, Fountoulakis M and Lubec G: Expression of hypothetical proteins in human fetal brain: increased expression of hypothetical protein 28.5kDa in Down syndrome, a clue for its tentative role. Mol Genet Metab 78: 295-301, 2003.
12. Cheon MS, Fountoulakis M, Dierssen M, Ferreres JC and Lubec G: Expression profiles of proteins in fetal brain with Down syndrome. J Neural Transm Suppl 61: 311-319, 2001.
13. Gulesserian T, Engidawork E, Fountoulakis M and Lubec G: Decreased brain levels of Lupus La protein and increased U5 small ribonucleoprotein-specific 40 kDa protein in fetal Down syndrome. Cell Mol Biol (Noisy-le-grand) 49: 733-738, 2003.
14. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
15. Weitzdoerfer R, Fountoulakis M and Lubec G: Reduction of actin-related protein complex 2/3 in fetal Down syndrome brain. Biochem Biophys Res Commun 293: 836-841, 2002.
16. Berndt P, Hobohm U and Langen H: Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints. Electrophoresis 20: 3521-3526, 1999.
17. Press WM, Teukolsky SA, Vetterling WT and Flannery BP: Nonlinear Models. In: Numerical Recipes in C. The Art of Scientific Computing (Second Edition). Cambridge, Cambridge University Press, 1992, pp. 683-688
18. Rockwood AL, VanOrden SL and Smith R: Rapid calculation of isotope distributions. Anal Chem 67: 2699-2704, 1995.
19. Peyrl A, Krapfenbauer K, Slavc I, Strobel T and Lubec G: Proteomic characterization of the human cortical neuronal cell line HCN-2. J Chem Neuroanat 26: 171-178, 2003.
20. Fountoulakis M, Schuller E, Hardmeier R, Berndt P and Lubec G: Rat brain proteins: two-dimensional protein database and variations in the expression level. Electrophoresis 20: 3572-3579, 1999.
21. Karlsson K, Cairns N, Lubec G and Fountoulakis M: Enrichment of human brain proteins by heparin chromatography. Electrophoresis 20: 2970-2976, 1999.
22. Langen H, Berndt P, Roder D, Cairns N, Lubec G and Fountoulakis M: Two-dimensional map of human brain proteins. Electrophoresis 20: 907-916, 1999.
23. Vlkolinsky R, Cairns N, Fountoulakis M and Lubec G: Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease. Neurobiol Aging 22: 547-553, 2001.
24. Perreau J, Lilienbaum A, Vasseur M and Paulin D: Nucleotide sequence of the human vimentin gene and regulation of its transcription in tissues and cultured cells. Gene 62: 7-16, 1988.
25. Duncan R, Bazar L, Michelotti G, Tomonaga T, Krutzsch H, Avigan M and Levens D: A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev 8: 465-480, 1994.
26. Raetz EA, Kim MK, Moos P, Carlson M, Bruggers C, Hooper DK, Foot L, Liu T, Seeger R and Carroll WL: Identification of genes that are regulated transcriptionally by Myc in childhood tumors. Cancer 98: 841-853, 2003.
27. Wagner DS, Gan L and Klein WH: Identification of a differentially expressed RNA helicase by gene trapping. Biochem Biophys Res Commun 262: 677-684, 1999.
28. Levi A, Eldridge JD and Paterson BM: Molecular cloning of a gene sequence regulated by nerve growth factor. Science 229: 393-395, 1985.
29. Lombardo A, Rabacchi SA, Cremisi F, Pizzorusso T, Cenni MC, Possenti R, Barsacchi G and Maffei L: A developmentally regulated nerve growth factor-induced gene, VGF, is expressed in geniculocortical afferents during synaptogenesis. Neuroscience 65: 997-1008, 1995.
30. Snyder SE, Pintar JE and Salton SR: Developmental expression of VGF mRNA in the prenatal and postnatal rat. J Comp Neurol 394: 64-90, 1998.
31. Brett D, Whitehouse S, Antonson P, Shipley J, Cooper C and Goodwin G: The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies. Hum Mol Genet 6: 1559-1564, 1997.
32. Delauney AJ and Verma DP: A soybean gene encoding delta 1-pyrroline-5-carboxylate reductase was isolated by functional complementation in Escherichia coli and is found to be osmoregulated. Mol Gen Genet 221: 299-305, 1990.
33. Minami-Ishii N, Taketani S, Osumi T and Hashimoto T: Molecular cloning and sequence analysis of the cDNA for rat mitochondrial enoyl-CoA hydratase. Structural and evolutionary relationships linked to the bifunctional enzyme of the peroxisomal beta-oxidation system. Eur J Biochem 185: 73-78, 1989.
34. Muller-Newen G and Stoffel W: Mitochondrial 3-2trans-enoyl-CoA isomerase. Purification, cloning, expression, and mitochondrial import of the key enzyme of unsaturated fatty acid beta-oxidation. Biol Chem Hoppe Seyler 372: 613-624, 1991.
35. Fountoulakis M: Proteomics: current technologies and applications in neurological disorder and toxicology. Amino Acids 21: 363-381, 2001.